WIPF3 Antikörper (C-Term) (HRP)
Kurzübersicht für WIPF3 Antikörper (C-Term) (HRP) (ABIN8053935)
Target
Alle WIPF3 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Verwendungszweck
- Anti-WIPF3 Antibody HRP Conjugated
-
Kreuzreaktivität (Details)
- No cross-reactivity with other proteins.
-
Aufreinigung
- Immunogen affinity purified.
-
Immunogen
- A synthetic peptide corresponding to a sequence at the C-terminus of human WIPF3, which shares 95.5% and 90.9% amino acid (aa) sequence identity with mouse and rat WIPF3, respectively.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Western blot, Optimal dilutions should be determined by end users. Immunohistochemistry (Paraffin-embedded Section), Optimal dilutions should be determined by end users. ELISA, Optimal dilutions should be determined by end users.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing.
-
Haltbarkeit
- 12 months
-
-
- WIPF3 (WAS/WASL Interacting Protein Family, Member 3 (WIPF3))
-
Andere Bezeichnung
- WIPF3
-
Hintergrund
-
Background: Predicted to enable SH3 domain binding activity and actin binding activity. Predicted to be involved in actin filament-based movement. Predicted to be located in cytosol. Predicted to be active in actin filament.
Gene Full Name: WAS/WASL interacting protein family member 3
-
Gen-ID
- 644150
-
UniProt
- A6NGB9
Target
-